Expert Review of Anti-Infective Therapy

Article	Citations
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	116
Challenges in preserving antibiotic effectiveness: time for a novel approach	87
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	57
Neonatal ocular prophylaxis in the United States: is it still necessary?	53
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	52
Visceral leishmaniasis elimination in India: progress and the road ahead	47
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	47
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	41
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	39
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	37
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	36
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	34
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	34
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	33
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	32
Reemergence of monkeypox: prevention and management	31
Difficile to treat: advanced management strategies in difficult to treat Clostridioides difficile infections	31
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	30
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	29
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?	27
Can Saccharomyces cerevisiae be used as a therapeutic agent for vulvovaginal candidiasis?	26
Treatment of vaginitis caused by non-albicans Candida species	26
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	26
Identifying predictors of treatment failure with community-acquired pneumonia: an update	26

Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	25
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	24
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	23
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?	22
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	21
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective	21
Treatment of pulmonary mucormycosis: current concepts	21
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections	20
Diagnostic and clinical management of Candida auris infections in immunocompromised patients	20
Advances in therapeutic strategies against Mycobacterium marinum infection	20
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	20
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges	19
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance	19
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges	19
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases	19
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19	19
Diagnostic and management strategies for chronic hepatitis E infection	19
One health and resistant fungi: a challenging balancing act between food security and patient survival	19
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases	18
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta	18
Infliximab as a potential treatment for COVID-19	17
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies	17
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	17
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures	16
Correction	16
Statement of Retraction	16
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?	16
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat	16
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches	15
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections	15
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India	15
Risk of HIV viral rebound after SARS-CoV-2 infection among people living with HIV on antiretroviral therapy: a retrospective matched cohort study	15
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	15
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential	15
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	14
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	14
The serological dilemma: rethinking syphilis treatment evaluation	14
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae	13
Monoclonal antibodies for the treatment of COVID-19 infection in children	13
Inhibiting horizontal gene transfer to contain antimicrobial resistance: conjugation and plasmid maintenance as druggable targets	13
The evolving debate around screening for Chlamydia trachomatis	13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	13
Diagnosing fungal infections in clinical practice: a narrative review	13
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea	12
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	12
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	12
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	12
How can we tackle the overuse of antibiotics in low- and middle-income countries?	11
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	11
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	11

Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	11
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	11
Disruptive innovation in antibiotic development: a vision for lysins	11
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	11
Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority	11
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	11
Challenges associated with pertussis detection, monitoring, and vaccination in adults	11
Precision antibiotic treatment in intensive care unit-acquired lower respiratory tract infections (ICU-LRTIs): contemporary concepts and future directions	11
Gram-positive infections in special populations. Expert view on the role of dalbavancin	10
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	10
Tocilizumab for the treatment of COVID-19	10
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	10
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	10
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	10
Now that griseofulvin is not available, what to do with tinea capitis treatments?	10
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	10
Unmet targets: evaluating vancomycin use and predictive factors of target attainment in hemodialysis patients	10
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	10
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	10
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance	10
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	10
A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China	10
New insights into the treatment of acute otitis media	10
How do we best manage Clostridioides difficle infections in the elderly?	10
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	10
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients	10
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	9
Global importance of new treatment strategies to efforts to control hepatitis B virus	9
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	9
Comparative effectiveness of ceftaroline plus vancomycin or daptomycin versus vancomycin or daptomycin monotherapy for MRSA bacteremia: an updated systematic review and meta-analysis	9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	9
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis	9
Diagnosis of urinary tract infections in the pediatric population – current practices, advances and progress	9
Artificial intelligence and prescription of antibiotic therapy: present and future	9
Efficacy and safety of gepotidacin versus standard of-care antibiotics for the treatment of uncomplicated urogenital infections in adults and adolescents: a systematic review and meta-analysis	9
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	8
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	8
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV	8
Nucleos(t)ide analogue treatment in hepatitis B: to stop or not to stop?	8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	8
The effect of combination antibiotic therapy on mortality in patients with sepsis or septic shock due to Pseudomonas aeruginosa bloodstream infections: a	8
The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis	8
Past, present, and future perspectives on aztreonam and avibactam	8
An update on newer antifungals	8
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	8
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	8
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon	8
How can the use of digital molecular diagnostic tools help to tackle malaria?	7
Host defense mechanisms against Candida auris	7
Non-cancerous complications in HTLV-1 carriers	7
Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review	7
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis	7
Effectiveness of bundles to prevent surgical site infections in cranial neurosurgery: systematic review, meta-analysis, and GRADE evaluation	7
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	7
HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity	7
Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection	7
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis	7
An update on antimicrobial selection and duration for intra-abdominal infections	7
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?	7
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	7
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	7
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow	7
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	7
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta	7
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak	7
Can probiotics replace antibiotics? Not yet, says the evidence	7
Brincidofovir in the Era of Mpox	7
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	7
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	7
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system	6
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	6
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	6
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	6
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	6
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	6
Update on the diagnosis, pathophysiology and treatment strategies in non-HIV-associated cryptococcal meningoencephalitis	6
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	6
How do we change our approach to COVID with the changing face of disease?	6
Langya henipavirus outbreak	6

Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	6
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	6
The impact of gender inequities on antimicrobial resistance in low-income countries: a comprehensive review	6
Genomic surveillance of Neisseria gonorrhoeae : a crucial tool in the global fight against antimicrobial resistance	6
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	6
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	6
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	6
HIV postnatal prophylaxis: how long is long enough?	6
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	6
Current perspectives of bacteriophage therapy for multidrug-resistant wound infections	6
Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis	5
COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval	5
Why do we urgently need a new treatment for cerebral aspergillosis?	5
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution	5
Evaluating long-acting injectable HIV treatment: an update on cabotegravir and rilpivirine	5
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges	5
Omadacycline in treating community-based infections: a review and expert perspective	5
Typical and atypical clinical profiles in syphilis patients: will genotyping of syphilis agents and patients help to explain symptom differences?	5
Letter to the editor: “real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients”	5
Phage therapy: innovations, challenges, and future directions in combating superbugs and antibiotic resistance	5
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	5
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	5
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis	5
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials	5
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	5
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	5
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	5
An evaluation of sipavibart for pre-exposure prophylaxis of COVID-19 in immunocompromised individuals	5
Antibiotic resistance in low- and middle-income countries: current practices and its global implications	5
Nirmatrelvir/ritonavir: real world drug–drug interaction management experience	5
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis	5
Letter to the Editor: the earliest observation of bla NDM was in Israel	5
From guesswork to guidelines: advancing diagnostic stewardship in immunocompromised hosts	5
Candida auris biofilm: a review on model to mechanism conservation	5
Artificial intelligence and its application in clinical microbiology	5
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	4
Updates in the clinical management of tuberculous meningitis	4
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	4
From Data to Decisions: Leveraging Large, Real-World Databases to Guide Clinical Practice in C. difficile Infections	4
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	4
Sepsis management in the antimicrobial resistance era	4
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway	4
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	4
Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States	4
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis	4
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis	4
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	4
Penile microbiomes have important implications for HIV susceptibility and broader reproductive health	4
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	4
Impact of nirmatrelvir/ritonavir on the risk of long COVID in outpatients: a systematic review and meta-analysis	4
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	4
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants	4
Antimicrobial management of complex biofilms in diabetic foot ulcers: a microbiological perspective	4
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	4
Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice	4
The antifungal pipeline for invasive fungal diseases: what does the future hold?	4
Therapeutic strategies to address monkeypox	4
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	4
Visited India? Metronidazole may not cure your Giardia infection	4
Biosimilars as antivirals: opportunities and challenges	4
Immunocompromised patients and COVID-19: how do we protect those most at risk?	4
Personalized care approaches to hepatitis C therapy: recent advances and future directions	4
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence	4
Secnidazole: a treatment for trichomoniasis in adolescents and adults	4